tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ACRS Stock Latest News

Aclaris Therapeutics completes patient enrollment in Phase 2 trial of bosakitug
The FlyAclaris Therapeutics completes patient enrollment in Phase 2 trial of bosakitug
5d ago
ACRS
Helus Pharma appoints Conwell as Chief People Officer
PremiumThe Fly
Helus Pharma appoints Conwell as Chief People Officer
11d ago
ACRS
HELP
Aclaris Therapeutics Raises $20 Million in Equity Financing
PremiumCompany Announcements
Aclaris Therapeutics Raises $20 Million in Equity Financing
12d ago
8K
ACRS
Aclaris Therapeutics Raises Capital via Institutional Stock Sale
PremiumCompany Announcements
Aclaris Therapeutics Raises Capital via Institutional Stock Sale
13d ago
8K
ACRS
Aclaris Therapeutics reports Q4 EPS (16c), consensus (14c)
PremiumThe Fly
Aclaris Therapeutics reports Q4 EPS (16c), consensus (14c)
25d ago
ACRS
Aclaris Therapeutics reports Q4 EPS (16c), consensus (14c)
PremiumThe FlyAclaris Therapeutics reports Q4 EPS (16c), consensus (14c)
25d ago
ACRS
Aclaris Therapeutics initiates Phase 1b PoC trial of ATI-052
Premium
The Fly
Aclaris Therapeutics initiates Phase 1b PoC trial of ATI-052
27d ago
ACRS
Aclaris Therapeutics initiated with a Buy at Craig-Hallum
Premium
The Fly
Aclaris Therapeutics initiated with a Buy at Craig-Hallum
2M ago
ACRS
Craig-Hallum bullish on Aclaris Therapeutics, initiates with a Buy
PremiumThe Fly
Craig-Hallum bullish on Aclaris Therapeutics, initiates with a Buy
2M ago
ACRS
Aclaris Therapeutics reports ‘positive’ results from ATI-2138
PremiumThe Fly
Aclaris Therapeutics reports ‘positive’ results from ATI-2138
2M ago
ACRS
Aclaris Therapeutics initiates Phase 1b proof-of-concept trial of ATI-052
PremiumThe Fly
Aclaris Therapeutics initiates Phase 1b proof-of-concept trial of ATI-052
2M ago
ACRS
Aclaris Therapeutics Expands Inflammation and Immunology Pipeline Strategy
PremiumCompany Announcements
Aclaris Therapeutics Expands Inflammation and Immunology Pipeline Strategy
2M ago
8K
ACRS
Aclaris advances ATI-052 after positive Phase 1a results
PremiumCompany AnnouncementsAclaris advances ATI-052 after positive Phase 1a results
3M ago
8K
ACRS
Aclaris Therapeutics reports ‘positive’ results from Phase 1a trial of ATI-052
Premium
The Fly
Aclaris Therapeutics reports ‘positive’ results from Phase 1a trial of ATI-052
3M ago
ACRS
Aclaris Therapeutics added to Nasdaq Biotechnology Index
Premium
The Fly
Aclaris Therapeutics added to Nasdaq Biotechnology Index
3M ago
ACRS
Aclaris Therapeutics management to meet with Cantor
PremiumThe Fly
Aclaris Therapeutics management to meet with Cantor
4M ago
ACRS
Aclaris Therapeutics: Promising Pipeline and Strategic Financial Management Justify Buy Rating
PremiumRatings
Aclaris Therapeutics: Promising Pipeline and Strategic Financial Management Justify Buy Rating
4M ago
ACRS
Aclaris Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Aclaris Therapeutics Reports Q3 2025 Financial Results
5M ago
ACRS
Aclaris Therapeutics reports Q3 EPS (12c), consensus (14c)
PremiumThe Fly
Aclaris Therapeutics reports Q3 EPS (12c), consensus (14c)
5M ago
ACRS
ACRS Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsACRS Upcoming Earnings Report: What to Expect?
5M ago
ACRS
Aclaris Therapeutics’ ATI-045 Study: A Potential Game-Changer for Atopic Dermatitis
Premium
Company Announcements
Aclaris Therapeutics’ ATI-045 Study: A Potential Game-Changer for Atopic Dermatitis
5M ago
ACRS
Aclaris Therapeutics: Promising Pipeline and Strategic Advancements Drive Buy Rating
Premium
Ratings
Aclaris Therapeutics: Promising Pipeline and Strategic Advancements Drive Buy Rating
5M ago
ACRS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >